Biomarkers of Hand Osteoarthritis

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2017 Nov 4

PMID 29098370

Citations 9

Authors

Tereza Lennerova

Karel Pavelka

Ladislav Senolt

Affiliations

Soon will be listed here.

Abstract

Hand osteoarthritis (OA) is a common degenerative joint disorder leading to substantial pain and disability. The most severe subtype is erosive hand OA characterized by an abrupt onset, local inflammation, subchondral erosions and worse outcomes than non-erosive disease. Biomarkers of hand OA could help to diagnose the disease earlier, to distinguish patients with erosive and non-erosive forms, to assess disease severity or to predict its future progression. The objective of this review was to summarize the role of potential biomarkers of hand OA. A PubMed search for soluble biomarkers associated with hand OA was performed from inception to June 2017. In total, 21 relevant publications were found and reviewed. These publications identified 20 potential biomarkers of hand OA. C-terminal cross-linking telopeptide of type II collagen, cartilage oligomeric matrix protein, osteocalcin, hyaluronan, urinary pentosidine, vascular cell adhesion molecule 1, monocyte chemotactic protein 1, osteoprotegerin and interleukin 1 have been shown as potential biomarkers for assessing disease severity. C-terminal cross-linking telopeptide of type I collagen, hyaluronan, urinary pentosidine and myeloperoxidase were shown to differentiate between erosive and non-erosive hand OA patients. A number of biomarkers reflecting joint tissue metabolism and inflammation have been studied in hand OA. Some were identified as potential biomarkers of disease severity and progression, others were shown to differentiate between erosive and non-erosive disease. However, further research is necessary to assess the value of biomarkers for use in clinical practice.

Citing Articles

Biochemical markers in hand osteoarthritis: a path to precision medicine.

Moraliyska R, Georgiev T Rheumatol Int. 2025; 45(2):38.

PMID: 39875697 DOI: 10.1007/s00296-025-05792-9.

An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis.

Bawa Z, Lewis D, Gavin P, Libinaki R, Joubran L, El-Tamimy M Sci Rep. 2024; 14(1):11792.

PMID: 38783008 PMC: 11116491. DOI: 10.1038/s41598-024-62428-x.

Soluble and EV-Associated Diagnostic and Prognostic Biomarkers in Knee Osteoarthritis Pathology and Detection.

Moravek M, Matejova J, Spakova T Life (Basel). 2023; 13(2).

PMID: 36836699 PMC: 9961153. DOI: 10.3390/life13020342.

Study protocol for the follow-up examination of the Nor-Hand study: A hospital-based observational cohort study exploring pain and biomarkers in people with hand osteoarthritis.

Gloersen M, Steen Pettersen P, Maugesten O, Mulrooney E, Mathiessen A, Gammelsrud H Osteoarthr Cartil Open. 2022; 3(3):100198.

PMID: 36474811 PMC: 9718069. DOI: 10.1016/j.ocarto.2021.100198.

Benefits of electroacupuncture and a swimming association when compared with isolated protocols in an osteoarthritis model.

Martins G, Degen A, Antunes F, da Rosa L, Ferraz A, Wiilland E J Tradit Complement Med. 2022; 12(4):375-383.

PMID: 35747360 PMC: 9209859. DOI: 10.1016/j.jtcme.2021.11.002.

References

Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J, Fahmi H . Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2010; 7(1):33-42. DOI: 10.1038/nrrheum.2010.196. View

Melgarejo E, Medina M, Sanchez-Jimenez F, Urdiales J . Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol. 2008; 41(5):998-1001. DOI: 10.1016/j.biocel.2008.07.018. View

. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

Rosenberg K, Olsson H, Morgelin M, Heinegard D . Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem. 1998; 273(32):20397-403. DOI: 10.1074/jbc.273.32.20397. View

Bauer D, Hunter D, Abramson S, Attur M, Corr M, Felson D . Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006; 14(8):723-7. DOI: 10.1016/j.joca.2006.04.001. View

Chen T, Chen L, Hsieh M, Chang C, Chou D, Tsai S . Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta. 2006; 1762(8):711-8. DOI: 10.1016/j.bbadis.2006.06.008. View

Filkova M, Senolt L, Braun M, Hulejova H, Pavelkova A, Sleglova O . Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. Osteoarthritis Cartilage. 2009; 17(12):1615-9. DOI: 10.1016/j.joca.2009.06.002. View

Bay-Jensen A, Reker D, Kjelgaard-Petersen C, Mobasheri A, Karsdal M, Ladel C . Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria. Osteoarthritis Cartilage. 2015; 24(1):9-20. DOI: 10.1016/j.joca.2015.10.014. View

Fledelius C, Johnsen A, Cloos P, Bonde M, Qvist P . Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region. J Biol Chem. 1997; 272(15):9755-63. DOI: 10.1074/jbc.272.15.9755. View

10.

Steinbeck M, Nesti L, Sharkey P, Parvizi J . Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease. J Orthop Res. 2007; 25(9):1128-35. PMC: 2954494. DOI: 10.1002/jor.20400. View

11.

Ryan M, Sandell L . Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem. 1990; 265(18):10334-9. View

12.

Pavelka K, Forejtova S, Olejarova M, Gatterova J, Senolt L, Spacek P . Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage. 2004; 12(4):277-83. DOI: 10.1016/j.joca.2004.01.001. View

13.

Barr A, Dube B, Hensor E, Kingsbury S, Peat G, Bowes M . The relationship between three-dimensional knee MRI bone shape and total knee replacement-a case control study: data from the Osteoarthritis Initiative. Rheumatology (Oxford). 2016; 55(9):1585-93. PMC: 4993955. DOI: 10.1093/rheumatology/kew191. View

14.

Chen F, Herndon M, Patel N, Hecht J, Tuan R, Lawler J . Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem. 2007; 282(34):24591-8. PMC: 2905148. DOI: 10.1074/jbc.M611390200. View

15.

Lee N, Sowa H, Hinoi E, Ferron M, Ahn J, Confavreux C . Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130(3):456-69. PMC: 2013746. DOI: 10.1016/j.cell.2007.05.047. View

16.

Gabay C, Medinger-Sadowski C, Gascon D, Kolo F, Finckh A . Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum. 2011; 63(11):3383-91. DOI: 10.1002/art.30574. View

17.

Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, Luthy R . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2):309-19. DOI: 10.1016/s0092-8674(00)80209-3. View

18.

DiCesare P, Hauser N, Lehman D, Pasumarti S, Paulsson M . Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett. 1994; 354(2):237-40. DOI: 10.1016/0014-5793(94)01134-6. View

19.

Saltzherr M, Selles R, Bierma-Zeinstra S, Muradin G, Coert J, van Neck J . Metric properties of advanced imaging methods in osteoarthritis of the hand: a systematic review. Ann Rheum Dis. 2013; 73(2):365-75. DOI: 10.1136/annrheumdis-2012-202515. View

20.

Deberg M, Labasse A, Christgau S, Cloos P, Henriksen D, Chapelle J . New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage. 2005; 13(3):258-65. DOI: 10.1016/j.joca.2004.12.002. View